InstructorRoyed Training
TypeOnline Course
Price$890 / 41830 INR.
Buy NowBook Now
free resources at royed training
pharma global management


Nature of course

Course Duration




Related Courses

About Pharma Management

Add on Certification

pharma global management

Pharma global management course provides hands on training to enhance skill competency of pharmaceutical middle and top level managers. This course ideal for the working professionals of pharmaceutical and biopharmaceutical industry. This comprehensive pharma global management training involves the real life job simulation. Hence, the course provides practical knowledge. Moreover, this course focuses on how pharma business development, strategic management, regulatory and licensing professionals working in the company. Therefore, it helps advance professionals to acquire cutting edged business skills. 

In these online self-paced modules, participants understands about the development to commercialization process in detail. In other words, you will understand portfolio strategic management. Hence, the course covers fundamentals to advance learning on various skill areas. 

Who should attend this course? 

  • Those who are in the regulatory affairs and related department.
  • Professionals from strategic management. 
  • Those who are in business development and licensing department.
  • This pharma global management course is ideal for the senior management professionals working in pharmaceutical and biopharmaceutical project management.
  • Anyone requiring an overview and detail understanding on working of pharmaceutical management. 
  • Fresher or beginners, Those who want to make a career in the management in pharmaceutical and biopharmaceutical company. 

Course Code: RYD-080

Title: Executive PG Certification in Pharma Global Management (EPPGB)

Type of the course: Self paced Online Course

Online distance learning course. Hence, this course can be accessed online across anywhere 24×7. Moreover, you can attend the course at your convenience in your flexible time. For example, you want to attend the session at your 11 pm at night, you can do that.

1 Year

Any body who wants to acquire drug regulatory affairs competency should attend the course.

Certificate will be provided at the end of the successful completion of the course

Features of Pharma Global Management Course

  • This pharma global management covers all aspects of the strategic management from drug discovery development, regulatory, commercialization, marketing, branding, business development and sales. Hence the course provides
  • The course provides orientation to job related practical aspects of the business development managers. Therefore, on completion of the course, the participants will develop the hands on understanding how Business Development Professional works.
  • One of the important feature of the course is real life simulation on critical decision making process. Hence, these simulations help to enhance the licensing and  decision making skills which is the core aspects of the pharmaceutical management working.

Case Based Learning

  • Advance training on strategic management based on the various business regions.
  • Course covers regional business development requirements specific to US, EU, Middle East, GCC, MENA, African, ASEAN, Latam, China, Japan, India etc.
  • Access to Case Studies to learn about the drug commercialization steps. Hence, participants will develop advanced competency on strategic portfolio management.

Career in pharma global management

A career in pharma management is very challenging, but highly rewarding. But at the same time, it opens up lot of opportunities for trained professionals. Companies always look for the trained professionals with relevant experience for the pharma management department. This is because, the strategic management job covers a variety of disciplines. Hence, pharma management professional involved in drug development, discovery, regulatory submission, compliance, clinical trials, quality assurance, drug safety, pharmacovigilance, branding, business development and licensing. So, person who want to be successful in pharma management should have 360 degree knowledge in various domain of pharma business.

Knowledge of the various business regions is important

The pharmaceutical industry is growing at a rapid pace. But there is a rising concern over the safety and efficacy. Hence, the major objective of the pharma management professionals to learn various regional regulatory knowledge. In fact, regional regulatory knowledge will help them to become successful in international business management. Moreover, pharma regulations are evolving and changing every other day. Pharma Management Professionals must have thorough knowledge about the updated regulations. Sound regulatory knowledge helps them to take strategic decision effectively. Therefore, this course is ideal choice for the pharma management course which covers various domain.

About regulatory affairs job>> Learn here

  • The participants of Global Business Registrant will get two add on certification.
  • Participant can choose add on courses of any 1 month or 1 week / 3 Days certification course. One can choose the desire course from following course list
  • Participant can activate the add on course anytime during 1 year active course duration.
  • On completion of add on course, participant will be issuing course certificate.
  • You can activate this add on course anytime during the active 1 year course tenure.
Section 1Pharma R&D Management- Discovery to Development | Strategic Management for US Market
Lecture 1R&D Process & Introduction to drug discovery
Lecture 2Investigational New Drug Application (INDA)
Lecture 3New Drug Application (NDA) 
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA) 
Lecture 6Review on Drug Discovery and Development 
Lecture 7Generic Drug User Fees Act  (GDUFA)
Lecture 8Prescription Drug User Fees Act (PDUFA)
Lecture 9Handling of orange book
Lecture 10USFDA expedited programs
Lecture 11Practical Training on INDA, NDA, ANDA filing
Lecture 12505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 13Authorized Generics: Key Understanding
Lecture 14Exploratory IND Vs. Traditional IND
Lecture 15Patents Vs. exclusivity 
Lecture 16Orphan Drug Designation 
Lecture 17Advance Learning on 505B2 Pathway
Lecture 18Chemistry, Manufacturing & Controls 
Lecture 19Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 20Clinical Trial : Detailed Understanding
Lecture 21Clinical Trial Protocol Writing
Lecture 22Ethics in Clinical Research
Lecture 23Informed Consent | Practical Training on preparing ICF | Ready Templates
Lecture 24FDA Forms and How to fill the resources
Lecture 25Strategic Discussion: PreIND, EOP1, EOP2 - What to expect !
Lecture 26Importance and Significance of Phase 2b Clinical Trial 
Lecture 27Regulatory Strategies in different phases of Clinical Trial
Lecture 28Para IV Filing - Strategic Insight
Lecture 29Para IV Notices
Lecture 30Evergreening - Patent Life Extension Strategies
Lecture 31Pay For Delay Strategy
Lecture 32REMS Strategic Planning 
Lecture 33Compulsory Licensing
Lecture 34Licensing & Technology Transfer
Lecture 35In-Licensing Vs. Outlicensing
Lecture 36LOE Strategies for Innovator Brands with case study
Lecture 37Pediatric Exclusivity and Pediatric Study Plan Development
Lecture 38Drug Repurposing
Lecture 39Advance understanding of the portfolio Management 
Lecture 40New Indication Approval Process and Promotion 
Lecture 41OTC Switch 
Lecture 42Detailed Understanding on 505(b)(2) VS. Suitability Petition : Case Based Learning
Lecture 43NCE Vs. 505b2 application - Case Based Learning 
Lecture 44FTF - 180 Days Exclusivity - Case Based Learning
Lecture 45Classic case study of the 505b2 filing : Case Based Learning
Lecture 46Strategic Planning in Combating 30 months stay strategies of innovator company- Case Based Learning
Lecture 47What is meaning of 'Pipeline in a Molecule'?
Lecture 48USFDA Emergency Use Authorization (EUA)
Lecture 49Target product profile (TPP) | Quality Target product profile (QTPP) | Critical Quality Attributes (CQAs) | Quality By Design (QbD)
Section 2Strategic Business Management - European Market
Lecture 50Introduction to EU Regulation 
Lecture 51Orientation to European Countries and National Regulatory Bodies
Lecture 52EU Drug Discovery Development to Commercialization (Step By Step)
Lecture 53Overview of EU Regulation 
Lecture 54EMA and EMA Authorisation Process
Lecture 55EU MA Application Types and Strategic Planning
Lecture 56EU MA Procedure - Centralised, Decentralised, Mutual Recognition, National Procedure 
Lecture 57EU MA Strategic Planning: Full, Full-mixed, hybrid applications. Generic, Similar biologic application pathway, Well-established use application, Fixed combination application, Informed consent application
Lecture 58Validity of the EU MA  - Renewal steps, Cessation of the marketing authorisation, Significance of "Placed in Union Market", Suspension or withdrawal & EU MA for licensed products
Lecture 59Data Exclusivity and Market Protection - Supplementary Patent Protection, Exclusivity, 6/10 Rule, 8+2+1 Formulae
Lecture 60EU Orphan Medicinal Products Regulation
Lecture 61Conditional marketing authorisation | Marketing authorisation under exceptional circumstances
Lecture 62Summary of Product Characteristics 
Lecture 63Compassionate Use
Lecture 64MHRA - UK Regulation 
Lecture 65The 'sunset clause' for marketing authorisation of pharmaceuticals
Lecture 66Paediatric use marketing authorisation (PUMA) & Paediatric Investigation Plan (PIP) - EU Requirments
Lecture 67EU Prime Designation
Lecture 68Accelerated assessment by EMEA
Lecture 69EU Adaptive Pathway
Lecture 70European public assessment report (EPAR) - Importance, Component, Management, Updation 
Lecture 71SPOR  - Concept of Master Data Management  
Section 3Pharma International Business - Product Registration, Plant Certification, Dossier Preparation and Export Documentation
Lecture 72Introduction to Pharmaceutical Export
Lecture 73Introduction of Export Documentation | Understanding of important terminologies
Lecture 74Proforma Invoice - Detailed understanding how to prepare Proforma Invoice
Lecture 75Export Contract | Importance | Considerations | Things to include in Export Contract
Lecture 76Commercial Invoice | Importance | Differences with Proforma Invoice 
Lecture 77Custom House Agent | Role, Responsibilities, How they work | Freight Forwarder - Difference with CHA | Case Study
Lecture 78Letter of Credit | How it works | Different types of LC | LC terms and conditions | Sight LC | Case Studies
Lecture 79Bank Guarantee (BG) | How BG works | Differences between BG and LC | Applicability of BG
Lecture 80LC Discounting | How it works | How to calculate the LC discounting
Lecture 81Packing List | Importance | Things to include in packing list
Lecture 82Incoterms | 2020 Incoterms | Practical understanding on different types of Incoterms | Choosing the right incoterm
Lecture 83Logical selection of Incoterms | Landing in right incoterms for your business
Lecture 84Pre-shipment Certificate | COO |CVO| Fumigation Certificate | Preshipment Inspection Certificate | Certificate of Health
Lecture 85Transport Documents | Bill of Lading | Different Types of Bill of Lading | Airway Bill
Lecture 86Certification Pharmaceutical Companies / Plants
Lecture 87Airfreight calculation | Gross Weight | Tare Weight | New Weight | Volumetric Calculation | Freight rate calculation
Lecture 88Manufacturing License
Lecture 89Free Sale Certificate
Lecture 90CPP (Certificate of Pharmaceutical Product)
Lecture 91Certificate of Analysis
Lecture 92Certificate of Origin (COO)
Lecture 93Non-conviction certificate
Lecture 94ISO Certification
Lecture 95Common Technical Document (CTD)
Lecture 96Electronic Common Technical Document (ECTD)
Lecture 97Dossier Preparation focusing on drug registration in export countries 
Lecture 98Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study
Lecture 99Importance of effective dossier management
Lecture 100Detailed Understanding on ANDA Submission Dossier 
Lecture 101Prior Approval Submission 
Lecture 102Detailed Understanding on ANDA Fees
Lecture 103Discussion on 85 common deficiency in CTD submission dossier
Section 4Plant Management and Certification | Quality Management
Lecture 104Premises & Plant Layout Designing
Lecture 105Sanitation and Hygiene
Lecture 106Equipment Modules
Lecture 107Production Modules
Lecture 108Documentation
Lecture 109Quality Control
Lecture 110Product Complaint
Lecture 111Storage Module
Lecture 112Pharmaceutical SOPs Management from regulatory perspective
Lecture 113Establishment Inspection Report | 483 Observations | USFDA Warning Letter | Handling of FDA inspection | Closing of Warning Letter 
Lecture 114Data Integrity issues in Pharmaceutical Industry
Lecture 115Electronic Batch Record for effective compliance management | Key Understanding | Functionalities | Importance in managing data integrity
Section 5Biopharmaceutical Management and Regulation
Lecture 116Introduction : Biopharmaceuticals
Lecture 117Classification of Biopharmaceutical 
Lecture 118Important Concept regarding Biopharmaceuticals
Lecture 119Principle of Naming of Biologics
Lecture 120Global Biologics Market
Lecture 121Recombinant protein
Lecture 122Monoclonal Antibodies Vs. Polyclonal Antibodies
Lecture 123Monoclonal Antibodies
Lecture 124Synthetic Immunomodulators
Lecture 125Production of Monoclonal Antibodies
Lecture 126Cytokines
Lecture 127Interferon
Lecture 128Erythropoiesis-stimulating agent
Lecture 129Biological Licensing Application (BLA) 
Lecture 130Abbreviated Biosimilar Application - 351(k): Advance Strategic Planning Process : Originator Vs. Biosimilar Development and Regulatory Approval Process | Reference Biologic | Purple Book | Data Requirements
Lecture 131Purple Book: Significance | Searching | Assignments
Lecture 132Vaccine development and approval Process
Lecture 133PDUFA For Biologics
Lecture 134Biosimilar Development Process
Lecture 135Strategic Consideration for Biosimilar Development 
Lecture 136Bio-Manufacturing Process Information
Lecture 137Studies required for approval of biosimilar
Section 6Pharma Global Brand Management
Lecture 138Marketing Orientation
Lecture 139Why Is Market Research Important in Pharmaceutical Business?
Lecture 140Market Research - Customer Engagement through feedback mechanism 
Lecture 141Product Life cycle 
Lecture 142Advance - Strategic Planning in Product Life cycle Management
Lecture 143Segmentation, Targeting and Positioning
Lecture 144Pricing
Lecture 145A Pharmaceutical Segmentation outlook
Lecture 146Distribution Channel in Pharmaceutical Industry 
Lecture 147Promotion in Pharmaceutical Industry : Communication Model, Effective promotional communication, Push Vs. Pull Strategy and Buying Decision Process
Lecture 148Practical understanding on Prescription Accelerating Materials used in pharmaceutical promotion
Lecture 149Method of Promotional Budgeting
Lecture 150Brand Recall | Brand Recognition |Top of mind - How to calculate brand recall value?
Lecture 151Advertising - Introduction | Objective | Types of Advertising 
Lecture 152ATL, BTL & TTL Advertising
Lecture 153Advertising Agency - Understanding on various types of advertising agency
Lecture 154Selection of Advertising Agency
Lecture 155What is creative Briefing? How to Prepare !
Lecture 156Creative Briefing - Practical Simulation
Lecture 157Request for Proposal | Concepts in advertising
Lecture 158Advertising Message Strategy Development and Evaluation
Lecture 159Creative Approach and Styles
Lecture 160Steps of Development of Creatives
Lecture 161Advertisement Copy Development
Lecture 162How to prepare Ad Campaign Step By Step
Lecture 163Brand Name | Brand Logo | Designing of Brand Logo | Trademarking
Lecture 164Advance Understanding of Pharmaceutical Brand Logo Development 
Lecture 165Component of Brand Logo
Lecture 166Brand Name and Trademark Registration Process
Lecture 167Trademark Searching Process | Hands on Practical Training
Lecture 168How to design an excellent brand logo : Tricks of the trade
Lecture 169Logo colour theme | Colour system | Colour coding | Significance of colour
Lecture 170Few Case Studies related to brand names and logos
Lecture 171Can one innovator company keep 2 or more brand name?
Lecture 172Traditional Vs. Non-Traditional trademark | Significance of Colour in Pharma Branding 
Lecture 173Global Trademarking : Brand Protection Globally 
Lecture 174Logo Rebranding - Reasons | Practical Examples | How to handle logo rebranding | Forced Rebranding 
Lecture 175Brand Logo Development: Real Life Simulation
Lecture 176Tagline - Development, Finalization and Protection
Lecture 177Brand Tagline - Punchline
Lecture 178Pharma Brand Name Generator
Lecture 179Fundamental of Pharma Marketing Plan 
Lecture 180Basic Understanding how to launch a pharmaceutical product into the market
Lecture 181Practical Training on Marketing Plan Preparation with real life example
Lecture 182Marketing Campaign Development : Importance of Target Audience Segmentation for effective targeting 
Lecture 183Sample Marketing Plan 
Lecture 184Decide about brand USP -What to promote 
Lecture 185How to prepare promotogram. Download sample Promotogram
Lecture 186Importance and Handling of Cycle Meeting and its importance 
Lecture 187Sample Marketing Plan
Lecture 188Sample Marketing Plan
Lecture 189Sample Marketing Plan
Lecture 190CSR Campaign 
Lecture 191Increase the brand reach with advance segmentation
Lecture 192Concept of uniform branding for better brand acceptability
Lecture 193Concept of Brand Differentiation
Lecture 194Introduction to visual aid designing  | V3M Concept | Components of the visual aid page
Lecture 195Practical Training in visual aid designing  | Step By Step Visual Aid Preparation | Creative Designing | Guideline on Proofing | USPs to differentiate the visual aid 
Lecture 196Visual Aid Printing  | Establishing Visual Aid Printing Specs for effective management of the vendors 
Lecture 197Visual Aid Analysis with practical example
Lecture 198Guideline on visual aid development
Lecture 199Marketing Plan followed by Visual Aid Development
Lecture 200Visual Aid, Literature reference Sample
Lecture 201Interactive Visual Aid | E-detailing | Remote Detailing | Analysis of Animated Video based e-detailing visual aids 
Lecture 202Visual aid detailing story writing
Lecture 203Artwork Development Process in PMT Department
Lecture 204Product List and Reminder card development
Lecture 205Catch Cover Development
Lecture 206Packaging Development 
Lecture 207Prescribing Information and Patient Information Leaflet development
Lecture 208Pharma Packaging Case Studies
Lecture 209DHCP letter
Lecture 210Product Packshot Designing : Practical Knowledge
Lecture 211Creativity to develop brand essence
Lecture 212Advance Training on Pharmaceutical Packaging -  Creative Packaging for Brand Differentiation 
Lecture 213Unique identifier & anti-tampering device on outer packaging
Section 7Business Development | Licensing
Lecture 214Training on Basic Finance  |  Understanding Financial Statment | Income Statement | Balance Sheet | Cash Flow Statement
Lecture 215Moving Average | Moving Annual Total | YTD | How to calculate 
Lecture 216Compound Annual Growth Rate | CAGR Calculation
Lecture 217Business Development Job Functionality | Strategic Planning Process | Knowledge Area of Business Development | Lead targeting | Licensing term sheets
Lecture 218Portfolio Management Process | Portfolio Characteristics | Portfolio Analysis | Balancing the Portfolio | BD and Strategic Planning Department 
Lecture 219Identifying the corporate Need of business development | Objective – Strategy - Tactics | Portfolio constraints | SWOT | Numerical SWOT
Lecture 220Profiling and Searching | Objectives | Search Database | Creating Opportunity Anatomy for deal analysis | Mind Mapping | Searching Tools and Techniques - Web Search | Conference | Confidentaility - CDA | MTA
Lecture 221Numerical SWOT Practical training
Lecture 222Modelling and Deal Valuation - Top Down Model | Epidemiology data method | Complex Model | Forecasting | Heuristic or ‘prophesy’ method | Different value perspectives | Deal Structuring Structuring the deal
Lecture 223Market Size Determination - Market Share | Relative Market Share | Total Vs. Actual Vs. Penetrated Market
Lecture 224Forecasting : Tools and Techniques
Lecture 225Market Sizing & Forecasting Case Study
Lecture 226Royalty Management - Royalty structuring | Royalty Calculation Method| Tiered Royalties | Terms | Royalty Reductions | Royalty Stacking - Concept and Calculation | Minimum Annual Royalties | Reach through royalties
Lecture 227Average Royalty Rate
Lecture 228Factor affecting the Royalty Rate in Pharmaceutical and Biopharmaceutical Deal
Lecture 229Distribution Licensing | Geography | Indication Splitting | Exclusive and Non-Exclusive Licensing | Sub Licenses
Lecture 230Acquisition in Pharma  | Product Acquisition| Company Acquisitions| Steps in acquisition | Financing acquisition deals | Trademark Assignment Process
Lecture 231Joint Ventures in Pharmaceutical and Biopharmaceutical Industry
Lecture 233Indication Splitting | Concept | Implementation feasibility analysis 
Lecture 234Types of Deals from Discovery to Commercialization
Lecture 235What are the fundamental areas of business development
Lecture 236Licensing Term Sheet | Content Structuring | Sample Term Sheet
Lecture 237Licensing Payment Scheduling: Different Types
Lecture 238Valuation Methods: DCF | rNPV | Sunk Cost Method | Comparables | Sum of Parts | Deterministic Vs. Probabilistic rNPV |  Peak Sales - Max-Min Approach
Lecture 239Valuation Methods: EBITDA method of valuation | Enterprise Value and Enterprise Multiple Calculation
Lecture 240Negotiation Skill Training for BD personnel | Mind Mapping Tools | Practical Case Based Learning | Do and Don’ts in Pharma Business development Negotiations | Role of Scribes
Lecture 241Business Development Simulation and Decision Making | Early Stage VS. Late Stage Valuation Methodology | Stair Step Model
Lecture 242Types of Strategic Alliances: Unilateral technology licensing | Cross technology licensing | R&D contracts | R&D collaborations | Minority-equity-based R&D alliances | JV | Manufacturing and marketing agreements | big pharma firms with dedicated biotechnology firms 
Lecture 243Benchmarking | Benchmarking through consortium | How to use benchmarking for drug discovery development projects 
Section 8Pharma Digital Marketing
Lecture 244Introduction to Digital Marketing 
Lecture 245Inbound and outbound marketing in pharma | Types of inbound and outbound marketing 
Lecture 246Digital Media Marketing Macro-Environment Analysis | Mapping of online market place | Internet marketing conversion process | Conversion Process Digital VS. Traditional | Publisher revenue model | Affiliate revenue model
Lecture 247Digital Media Marketing Micro - Environment Analysis | Web server | Web browser | http vs. https - Significance and hands on understanding | Privacy and ethical issues in internet marketing
Lecture 248Digital marketing strategy development | Planning process | E-Marketing Plan | Planning for MNC Vs. Start Up | Strategic Outcome measurement
Lecture 249Relationship marketing using digital platform | CRM | Concept of permission marketing | User Satisfaction and loyalty management | Feedback mechanism
Lecture 250Campaign planning for digital media | Goal setting | Tracking | Campaign insight | Segmentation and targeting | Message Development | Media Mix Selection | Media scheduling | Practical understanding to campaign performance matrics | CPC | CPA | PPC | ROI | CPS
Lecture 251Search Engine Optimization | Search Engine Marketing | Social Media Marketing
Lecture 252Web Host - Check the hosting details 
Lecture 253Page Speed- importance and practical understanding | Check the web speed 
Lecture 254Keyword | Keyword Planning for SEO and SEM | Keyword Planner
Lecture 255Mobile Responsive | Tracking the Site 
Lecture 256HCP sites and Patient Site
Lecture 257Google Ad - Practical Training on Campaign Development and Execution
Lecture 258Digital Marketing Strategies for innovator brand | Pre launch - comuing soon, DSE Marketing | Launch activities - Day of approval (DOA) site | FDA Compliance | FDA 2253 Filing
Lecture 259Brand Portal Development
Lecture 260Relationship Marketing : KOL Management and Patient Advocacy Group 
Lecture 261Public Relation - PR firm | PR Campaign | Press Release | Technical understanding of press release writing | Digital Press Release
Lecture 262Developing Ad - Pharmaceutical Prescription, OTC Vs FMCG Brands
Lecture 263Difference between FMCG and OTC Brand Ad
Lecture 264Digital Marketing Techniques
Lecture 265Video Marketing
Lecture 266Video Marketing Techniques For Small Business Owners
Lecture 267Promoting Brand through Article Advertising and Marketing
Section 9Regional Business Development : Africa
Lecture 268African Continent Overview - Brief introduction
Lecture 269African Pharma Market
Lecture 270Drug Registration - African medicines regulatory
Lecture 271Basic Export Requirement for African Countries
Lecture 272Export Documentations & Important Concepts
Lecture 273Nigeria  - Drug Registration
Lecture 274Drug Registration in Algeria
Lecture 275Drug Registration in Ethiopia
Lecture 276Drug Registration in Kenya
Lecture 277Drug Registration in Egypt
Lecture 278Drug Registration in Ghana
Lecture 279Drug Registration in Botswana
Lecture 280Drug Registration in South Africa
Lecture 281Drug Registration in Zambia
Lecture 282Drug Registration in Namibia
Lecture 283Drug Registration in Tanzania
Lecture 284Drug Registration Senegal
Lecture 285Drug Registration in Zimbabwe
Lecture 286Drug Registration in Uganda
Lecture 287Drug Registration in Morocco
Lecture 288Drug Registration in Sudan
Section 10Regional Business Development : GCC, Middle East and MENA
Lecture 289GCC Pharmaceutical Market
Lecture 290GCC Registration Procedure - Centralized and Decentralized Procedure
Lecture 291Drug Registration in Saudi Arabia
Lecture 292Drug Registration in UAE
Lecture 293Drug Registration in Kuwait
Lecture 294Drug Registration in Bahrain
Lecture 295Drug Registration in Oman
Lecture 296Middle East Pharma Market
Lecture 297Drug Registration in Jordan
Lecture 298Drug Registration in Palestine
Lecture 299Drug Registration in Israel
Lecture 300Drug Registration in Syria
Lecture 301Drug Registration in Iran
Lecture 302Drug Registration in Iraq
Section 11Regional Business Development : ASEAN
Lecture 303ASEAN Drug Regulatory Affairs
Lecture 304Asean Geography 
Lecture 305Drug Registration in Brunei 
Lecture 306Drug Registration in Malaysia 
Lecture 307Drug Registration in Cambodia 
Lecture 308Drug Registration in Mayanmar 
Lecture 309Drug Registration in Philippines 
Lecture 310Drug Registration in Singapore 
Lecture 311Asean Common Technical Document (ACTD) 
Section 12Regional Business Development : Latam
Lecture 312Introduction to Latam Region Pharma Business Development
Lecture 313Drug Registration and Regulation in Argentina 
Lecture 314Drug Registration and Regulation in Bolivia
Lecture 315Drug Registration and Regulation in Brazil
Lecture 316Drug Registration and Regulation in Chile
Lecture 317Drug Registration and Regulation in Colombia
Lecture 318Drug Registration and Regulation in Mexico
Section 13Regional Business Development : Other Asian Countries
Lecture 319Drug Registration and Regulation in China
Lecture 320NMPA's DDR and DMR update
Lecture 321Drug Registration and Regulation in Japan
Lecture 322Drug Registration and Regulation in India
Section 14References and Case Studies
Lecture 323Comparison of various requirement of drug registration
Lecture 324Comparison of Dossier requirements of US and EU
Lecture 325Comparison of DMF requirement of various regulatory bodies